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 Is This Stricture Inflammatory? 
 Gerhard Rogler  
 Division of Gastroenterology and Hepatology, University Hospital of Zürich,  Zürich , Switzerland 
 Recent data indicate that ultrasound has similar spec-
ificity and sensitivity as compared to MRI for the evalu-
ation of CD activity  [7, 8] . Ultrasound has been shown to 
be useful for the clinical management of CD  [8–12] . Ul-
trasound results have been shown to be predictive for the 
disease behavior  [10–16] , which is of importance in the 
context of the study presented in this issue of  Digestion .
 Bowel wall thickness has been the most important 
readout in studies on the diagnostic value of ultrasound 
in IBD patients  [10, 11, 16–19] . In addition to simple mor-
phometry, contrast-enhanced ultrasound or splanchic 
artery blood flow measurements have been applied with 
mixed results  [12, 20–25] .
 Ultrasound has on one hand the great advantage of be-
ing readily available and non-invasive. It can be used re-
peatedly to monitor therapeutic success. On the other 
hand the subjective nature of ultrasound has been regard-
ed as its major disadvantage. Therefore, the aim of the 
study by Schirin-Sokhan and co-workers [26] was to de-
fine objective quantitative measures of stricture charac-
teristics (fibrostenotic vs. inflammatory) using contrast-
enhanced ultrasound in CD patients with small bowel 
stenosis. The authors prospectively recruited 18 consecu-
tive CD patients with a localized significant small bowel 
stenosis during a period of 18 months. They performed a 
standardized ultrasound examination, color-coded du-
plex sonography and contrast-enhanced ultrasound us-
ing SonoVue  . Bowel wall vascularity was quantified us-
ing computerized algorithms.
 Schirin-Sokhan et al. [26] found no significant correla-
tions between the vascularity parameters and the outcome 
in the clinical follow-up (which is the most important pa-
rameter) that would indicate a method for a clear sono-
 About 75% of all patients suffering from Crohn’s dis-
ease (CD) have to undergo surgery at least once during 
the course of their disease  [1–4] . In half of these patients, 
intestinal obstructions and strictures are the indication 
for surgery. This means that intestinal obstructions cause 
the need for abdominal surgery in approximately one 
third of all CD patients. In more than 45% of those pa-
tients the obstructions are recurrent.
 These data indicate that a stricturing disease course is 
still a major challenge in the clinical care of CD patients 
 [1] . As therapeutic options differ, it is of major impor-
tance for the clinical management if a stenosis is fibrotic, 
inflammatory or both (and in the latter case more fibrot-
ic or more inflammatory). An inflammatory stenosis 
would primarily be treated conservatively with (topical) 
steroids, immunosuppressants or biologicals. A fibrotic 
stenosis will not respond to such a treatment and should 
be operated early as a conservative approach may raise 
the risk for complete bowel obstruction.
 In clinical practice we usually apply different diagnos-
tic tools to discriminate between fibrotic and inflamma-
tory strictures. We use imaging techniques (such as MRI 
or CT and ultrasound), evaluate systemic parameters of 
inflammation (such as CRP or ESR), and quantify fecal 
markers of inflammation (such as calprotectin or lacto-
ferrin)  [5] . Sometimes we obtain sufficient information 
from such diagnostic techniques to make a decision, 
sometimes we do not have sufficient evidence for one or 
the other option. Therefore, frequently a probatory ste-
roid treatment will be performed. However, it has to be 
kept in mind that a steroid dose of more than 20 mg/day 
may increase the frequency of perioperative complica-
tions  [6] .
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graphic discrimination between fibrostenotic and inflam-
matory stenoses in CD patients. Certainly the results of 
this study have to be interpreted carefully due to the lim-
ited number of patients investigated. With a number of 
only 18 patients that may have had mixed (fibrotic and in-
flammatory) strictures it is very hard to find sufficient pos-
itive predictive values for a diagnostic technique.
 Whether the establishment of computerized algo-
rithms for objective quantification of bowel wall vascu-
larity will be helpful has to be evaluated by further stud-
ies. The study presented in this issue of  Digestion should 
stimulate such research.
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